V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160017043 | 160008461 | 1.61 | 58.6 | Palliative (P) | 2016-09-01 | 2016-09-12 | Doxorubicin 75mg/m2 | null | N | DOXORUBICIN | 101658857 |
| 160017044 | 160008462 | 1.77 | null | Curative (C) | null | 2017-07-03 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101125629 |
| 160017045 | 160008463 | 1.81 | 92.8 | null | 2019-08-10 | 2019-08-10 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100263234 |
| 160017050 | 160008464 | null | 74 | Palliative (P) | 2017-12-13 | 2017-12-28 | Carboplatin + Paclitaxel (weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100182398 |
| 160017051 | 160008465 | 1.7 | 73.7 | 03 | null | 2018-10-14 | EURO-EWING | null | N | CISPLATIN + DOXORUBICIN | 100887779 |
| 160017052 | 160008466 | 1.79 | 71.9 | Disease modification (D) | 2017-03-06 | 2017-03-13 | Cisplatin + Pemetrexed | 99 | N | CISPLATIN + PEMETREXED | 100940818 |
| 160017053 | 160008467 | 1.7 | 80.6 | Palliative (P) | 2017-10-08 | 2017-10-09 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100949152 |
| 160017054 | 160008468 | 1.75 | 85.8 | Palliative (P) | 2021-01-04 | 2021-01-10 | DOXORUBICIN | 01 | N | DOXORUBICIN | 101068411 |
| 160017055 | 160008469 | 1.68 | 65.25 | Palliative (P) | 2016-11-29 | 2016-12-24 | Doxorubicin + Ifosfamide | 02 | Y | TRIAL UNSPECIFIED | 100878610 |
| 160017057 | 160008470 | 1.61 | 84.7 | Palliative (P) | 2021-01-07 | 2021-01-07 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100296839 |
| 160017059 | 160008471 | 1.85 | 89.45 | null | 2017-12-17 | 2017-12-17 | DACARBAZINE + DOXORUBICIN | null | null | DA | 101091479 |
| 160017060 | 160008472 | 1.8 | 64.9 | Neo-adjuvant (N) | 2017-03-07 | 2017-03-21 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100239095 |
| 160017062 | 160008473 | 1.88 | 60.4 | Palliative (P) | 2018-09-26 | 2018-09-27 | DOXORUBICIN | N | N | EW EUROEWING 2012 ARM A VIDE | 101853493 |
| 160017067 | 160008474 | 1.58 | 73.4 | Palliative (P) | null | 2020-06-24 | IVA | 02 | N | DOXORUBICIN | 100157495 |
| 160017068 | 160008475 | 1.51 | 61 | Adjuvant (A) | 2018-05-21 | 2018-05-21 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100878394 |
| 160017069 | 160008476 | null | null | Curative (C) | 2018-11-13 | 2018-12-05 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 100975439 |
| 160017070 | 160008477 | 1.75 | 66 | null | 2017-05-13 | 2017-05-14 | DOXORUBICIN | N | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 101483443 |
| 160017072 | 160008478 | 1.57 | 57.8 | Curative (C) | 2017-05-04 | 2017-05-04 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101681453 |
| 160017074 | 160008479 | 1.7 | 104.6 | Neo-adjuvant (N) | 2018-02-26 | 2018-03-16 | IVADo | 02 | null | DOXORUBICIN + IFOSFAMIDE | 101361211 |
| 160017076 | 160008480 | 1.22 | 66.1 | Curative (C) | 2019-06-25 | 2019-07-04 | Carboplatin + Paclitaxel (3 weekly) | N | N | CARBOPLATIN + PACLITAXEL | 101525979 |
| 160017077 | 160008481 | 1.8 | 20.8 | Palliative (P) | 2016-10-25 | 2016-11-17 | NB HRNBL-1 COJEC Ind COURSE B | null | null | VINORELBINE | 100523964 |
| 160017078 | 160008482 | 1.63 | 69.2 | null | 2017-10-21 | 2017-11-12 | Dactinomycin + Vincristine | 02 | null | LIPOSOMAL DOXORUBICIN | 101464795 |
| 160017080 | 160008483 | 1.81 | 78.5 | Palliative (P) | 2021-04-27 | 2021-05-08 | Doxorubin 50mg/m2 | N | Y | TRIAL | 101292714 |
| 160017081 | 160008484 | 1.78 | 75 | null | 2017-03-04 | 2017-03-04 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | Y | DOXORUBICIN + IFOSFAMIDE | 100257167 |
| 160017082 | 160008485 | 1.67 | 77.4 | null | 2017-02-05 | 2017-02-09 | STS Rhabdomyosarcoma RMS 2005 IVAVV | Y | N | LIPOSOMAL DOXORUBICIN | 100720300 |
| 160017084 | 160008486 | 1.82 | 99.2 | Palliative (P) | 2016-09-16 | 2016-09-30 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | null | DOXORUBICIN + OLARATUMAB | 100699224 |
| 160017091 | 160008487 | 1.61 | 115 | Palliative (P) | 2018-07-29 | 2018-08-19 | CARBOPLATIN + PACLITAXEL | Y | N | CARBOPLATIN + PACLITAXEL | 101284569 |
| 160017092 | 160008488 | 1.73 | 87 | null | 2019-02-19 | 2019-03-02 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101391696 |
| 160017094 | 160008489 | 1.9 | 52.4 | Palliative (P) | 2018-03-30 | 2018-03-30 | DOXORUBICIN | 02 | N | STS RHABDO RMS 2005 VIN CYCLO | 101079775 |
| 160017098 | 160008490 | 1.7 | 66.8 | Palliative (P) | 2018-03-13 | 2018-03-15 | Doxorubicin 75mg/m2 | 02 | N | RITUXIMAB | 100806426 |
| 160017102 | 160008491 | 1.52 | 80.85 | Curative (C) | 2017-08-10 | 2017-08-20 | Vinorelbine IV | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100353353 |
| 160017103 | 160008492 | 1.68 | 77 | null | 2019-11-17 | 2019-11-19 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100423831 |
| 160017104 | 160008493 | 1.7 | 80 | Palliative (P) | 2021-08-09 | 2021-08-10 | VINCRISTINE | 2 | N | CARBOPLATIN + GEMCITABINE | 100822448 |
| 160017106 | 160008494 | 0 | 12.7 | Palliative (P) | 2018-11-19 | 2018-11-19 | null | Y | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100451101 |
| 160017109 | 160008495 | 1.68 | 79.1 | Palliative (P) | 2017-04-22 | 2017-04-28 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101100354 |
| 160017110 | 160008496 | 1.74 | 72 | Neo-adjuvant (N) | 2019-08-14 | 2019-09-10 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101070182 |
| 160017112 | 160008497 | 1.68 | 65.5 | Palliative (P) | 2019-02-04 | 2019-02-12 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101236376 |
| 160017114 | 160008498 | 1.7 | 88.4 | Palliative (P) | 2016-07-05 | 2016-07-19 | ETOP 13-18 BEAT-meso Trial | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101694963 |
| 160017115 | 160008499 | 1.56 | 82.7 | Palliative (P) | 2019-12-12 | 2019-12-21 | GEMCARBO | 02 | N | TRIAL | 101833931 |
| 160017118 | 160008501 | 1.7 | 62.4 | Palliative (P) | 2015-11-27 | 2015-12-05 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100573082 |
| 160017119 | 160008502 | 1.73 | 92 | Adjuvant (A) | 2019-06-13 | 2019-06-21 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100674859 |
| 160017126 | 160008503 | null | null | 03 | null | 2019-06-23 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 100677852 |
| 160017127 | 160008504 | 1.6 | 127.9 | Palliative (P) | 2019-06-07 | 2019-06-19 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101584547 |
| 160017128 | 160008505 | 1.6 | 62.5 | Palliative (P) | null | 2016-12-14 | Carboplatin + Paclitaxel (3 weekly) | N | N | CARBOPLATIN + PACLITAXEL | 100315424 |
| 160017129 | 160008506 | 0 | 9.2 | Palliative (P) | 2017-06-13 | 2017-06-21 | PACLITAXEL | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100423018 |
| 160017133 | 160008508 | 1.61 | 82.1 | Palliative (P) | 2017-12-28 | 2018-01-14 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100169062 |
| 160017137 | 160008509 | 1.79 | 90.5 | Palliative (P) | 2018-06-14 | 2018-07-11 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | IFOSFAMIDE + LIPOSOMAL DOXORUBICIN | 100575350 |
| 160017138 | 160008510 | 1.7 | 53.7 | Curative (C) | 2018-09-17 | 2018-10-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101530284 |
| 160017139 | 160008511 | 1.78 | 111.4 | Palliative (P) | 2018-10-01 | 2018-10-15 | GemCarbo Days 1+8 | 02 | N | BEP | 100237480 |
| 160017140 | 160008512 | 1.56 | 46.6 | Palliative (P) | 2019-11-27 | 2019-12-01 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100022048 |